Virginia Retirement Systems’s Pacira BioSciences PCRX Stock Holding History

Virginia Retirement Systems’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.28M	Buy	51,050 +17,500	+52%	+$443K	0.01%	643
2026 Q2	$851K	Buy	33,550 +6,300	+23%	+$149K	0.01%	808
2026 Q1	$616K	Sell	27,250 -10,900	-29%	-$242K	﹤0.01%	714
2025 Q4	$987K	Sell	38,150 -16,650	-30%	-$396K	0.01%	584
2025 Q3	$1.41M	Buy	54,800 +23,700	+76%	+$582K	0.01%	496
2025 Q2	$743K	Buy	31,100 +1,900	+7%	+$47.9K	0.01%	657
2025 Q1	$726K	Buy	+29,200	New	+$699K	0.01%	650
2023 Q3	–	Sell	-7,400	Closed	-$297K	–	1008
2023 Q2	$297K	Buy	+7,400	New	+$306K	﹤0.01%	841
2021 Q4	–	Sell	-6,800	Closed	-$381K	–	1145
2021 Q3	$381K	Sell	6,800 -700	-9%	-$40.3K	﹤0.01%	837
2021 Q2	$455K	Hold	7,500	–	–	﹤0.01%	844
2021 Q1	$526K	Buy	7,500 +200	+3%	+$14.3K	0.01%	869
2020 Q4	$437K	Buy	7,300 +1,800	+33%	+$105K	﹤0.01%	889
2020 Q3	$331K	Buy	+5,500	New	+$320K	﹤0.01%	902
2019 Q3	–	Sell	-6,500	Closed	-$283K	–	1172
2019 Q2	$283K	Hold	6,500	–	–	﹤0.01%	1038
2019 Q1	$247K	Buy	+6,500	New	+$254K	﹤0.01%	1016

Other funds holding PCRX

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Bridge City Capital Lake Oswego, Oregon $480M AUM 47.16% 1-Year Est. Return

Gagnon Advisors New York $182M AUM 52.04% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Virginia Retirement Systems's PCRX Position: Q3 2026 in Review

Virginia Retirement Systems increased its Pacira BioSciences (PCRX) stake by 52% in Q3 2026, buying an estimated $443K and bringing the position to 51,050 shares worth $1.28M. The position accounts for 0.01% of the portfolio, ranked #643.

Virginia Retirement Systems first reported a position in PCRX in Q1 2019 and has held it in 15 quarters since. The position peaked at $1.41M in Q3 2025. 107 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.

Virginia Retirement Systems held 51,050 shares of Pacira BioSciences worth $1.28M as of Q3 2026.
Virginia Retirement Systems bought 17,500 Pacira BioSciences shares in Q3 2026, an estimated $443K.
Pacira BioSciences made up 0.01% of Virginia Retirement Systems's portfolio in Q3 2026, its #643 holding.
Virginia Retirement Systems first reported a position in Pacira BioSciences in Q1 2019 and has held it in 15 quarters since.
Virginia Retirement Systems's Pacira BioSciences position peaked at $1.41M in Q3 2025.
107 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.

Based on Virginia Retirement Systems's 13F filing for Q3 2026, filed 28 Oct 2026.